UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-07 | Future report Set alerts | |
| Q2 2022 | 2022-08-03 | 0.28 | 0.28 |
| Q1 2022 | 2022-05-09 | 0.34 | 0.34 |
| Q4 2021 | 2022-03-15 | 0.32 | 0.32 |
| Q3 2021 | 2021-11-09 | 0.25 | 0.25 |
| Q2 2021 | 2021-08-09 | 0.28 | 0.28 |
| Q1 2021 | 2021-05-10 | 0.21 | 0.21 |
| Q4 2020 | 2021-03-09 | 0.37 | 0.37 |
| Q3 2020 | 2020-11-09 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-10 | 0.47 | -0.73 |
| 2016-05-16 | Reiterated Rating | Sterne Agee CRT | Buy | |
| 2016-05-12 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-12 | Boost Price Target | Citigroup Inc. | Buy | $18.00 to $19.00 |
| 2016-05-12 | Reiterated Rating | FBR & Co | Buy | |
| 2016-03-17 | Reiterated Rating | FBR & Co. | Buy | $21.50 |
| 2016-03-16 | Lower Price Target | Barclays | Equal Weight | $20.00 to $16.00 |
| 2016-03-16 | Lower Price Target | Barclays PLC | Equal Weight | $20.00 to $16.00 |
| 2015-05-22 | Reiterated Rating | JMP Securities | Outperform | $21.50 to $21.00 |
| 2015-05-13 | Reiterated Rating | JMP Securities | Outperform | $21.50 to $21.00 |
| 2014-11-14 | Lower Price Target | Citigroup Inc. | Buy | $22.00 to $21.00 |
| 2014-11-13 | Lower Price Target | Barclays | Overweight to Equal Weight | $24.00 to $20.00 |
| 2014-08-14 | Reiterated Rating | Citigroup Inc. | Buy | $21.00 to $22.00 |
| 2014-08-07 | Initiated Coverage | JMP Securities | Outperform | $21.50 |
| 2014-04-01 | Reiterated Rating | Morgan Stanley | Equal Weight | $20.00 to $21.00 |
| 2014-03-26 | Boost Price Target | Barclays | Overweight | $22.00 to $24.00 |
| 2013-10-30 | Initiated Coverage | Morgan Stanley | Overweight | |
| 2013-10-29 | Initiated Coverage | Sterne Agee CRT | Buy | |
| 2013-10-29 | Initiated Coverage | FBR & Co. | Outperform | $20.00 |
| 2013-10-29 | Initiated Coverage | Citigroup Inc. | Buy | |
| 2013-10-29 | Initiated Coverage | Barclays | Overweight | $22.00 |
| 2016-05-16 | Reiterated Rating | Sterne Agee CRT | Buy | |
| 2016-05-12 | Reiterated Rating | FBR & Co. | Buy | |
| 2016-05-12 | Boost Price Target | Citigroup Inc. | Buy | $18.00 to $19.00 |
| 2016-05-12 | Reiterated Rating | FBR & Co | Buy | |
| 2016-03-17 | Reiterated Rating | FBR & Co. | Buy | $21.50 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CHMI 45 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 0.85M |
| RENAISSANCE TECHNOLOGIES LLC | 0.76M |
| BlackRock Inc. | 0.35M |
| TWO SIGMA ADVISERS, LLC | 0.25M |
| BlackRock Fund Advisors | 0.17M |
| GEODE CAPITAL MANAGEMENT, LLC | 0.17M |
| TWO SIGMA INVESTMENTS LLC | 0.15M |
| LPL Financial LLC | 0.11M |
| MORGAN STANLEY | 0.11M |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 87230 |
| STATE STREET CORP | 59782 |
| Invesco Ltd. | 56497 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 50432 |
| CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 44700 |
| NORTHERN TRUST CORP | 39684 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Middleman Stanley C. | 13.32% (1000000) | CHMI / |
| KISLAK JONATHAN | 0.46% (34501) | CHMI / |
| Levine Martin Chief Financial Officer | 0.39% (29517) | CHMI / |
| Murin Joseph J | 0.18% (13233) | CHMI / |
| Lowrie Regina | 0.12% (9053) | CHMI / |
| Lown Jay Chief Investment Officer | 0.10% (7350) | CHMI / |
| Evans Julian Chief Investment Officer | 0.04% (3250) | CHMI / |
| Salcetti Robert A | 0.04% (3181) | CHMI / DX / OCN / |
| Mercer Robert C JR | 0.04% (2733) | CHMI / |
UM